Isracann announces plan to raise capital

Twitter icon

Click Here To View the Entire Article

Last month, Technical420 highlighted Isracann which has been focused on the Israeli cannabis market and is focused on becoming a premier, low-cost cannabis producer. The company has significant leverage to this attractive cannabis market and has secured three farms with cultivation licenses totaling 580,000 sq. ft.

Isracann has been working on further strengthening its balance sheet through a private placement and is well capitalized, having fully funded the buildout of 230,000 sq. ft. of cultivation facilities that can produce approx. 23,500 kilograms of premium cannabis on an annual basis. One of the important aspects of this opportunity pertains to this facility and how it gets licensed. The company’s facility is designed to be a IMC-GAP/GSP certified facility that will be constructed to meet all regulatory standards.

In late 2019, Isracann expects to complete its first harvest and plans to ramp up from there. The facility offers the company significant room to expand and we are favorable on this. We expect to see increasing demand for Israeli cannabis products and the focus on increasing production capacity is important for the company’s growth potential.

One of the reasons why we are excited about the Isracann opportunity is due to the climate in Israel as being ideal for cultivating cannabis. When you look at the economics associated with cultivating cannabis in Canada, you will see that it costs approx. $1.50 to $2.00 (on average) to produce each gram of cannabis. In Israel, the economics are much more attractive, and producers are able to grow cannabis for approx. $0.40 per gram. The leverage to the Israeli cannabis market is significant and we think economics will play a key role once the company starts cultivating cannabis. We see Israel as a potential major exporter to the European Union where cannabis legalization is being fast tracked and we are also seeing a rapidly maturing medical market. 

Announces Plans to Raise Capital

Earlier this month, Isracann announced plans to raise capital through a non-brokered private placement. The company will be raising capital concurrently with its initial public offering (IPO) and will be offering units for $0.17 each. Each unit will be comprised of one common share and a full purchase warrant (can be exercised at $0.34 for a period of 24-months after the closing of the financing. Upon closing of the financing, Isracann will execute a 3-1 reverse split.

Click Here To View the Entire Article

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Article category: 
Regional Marijuana News: